下一个

自动播放

Managing Avelumab Side Effects in Patients With Merkel Cell Carcinoma

2 意见 • 07/17/23
分享
嵌入
administrator
administrator
订户
0

Howard L. Kaufman, MD, FACS, chief surgical officer and associate director for clinical science at Rutgers Cancer Institute of New Jersey, discusses the adverse event profile of avelumab (Bavencio) for patients with Merkel cell carcinoma.

显示更多
0 注释 sort 排序方式
脸书评论

下一个

自动播放